| scholarly article | Q13442814 |
| P2093 | author name string | Harold Kim | |
| William J Muller | |||
| Richard Marcotte | |||
| Lixin Zhou | |||
| Calvin D Roskelly | |||
| P2860 | cites work | Newest findings on the oldest oncogene; how activated src does it | Q24313514 |
| pp60c-src activation in human colon carcinoma | Q24623701 | ||
| Activation and association of Stat3 with Src in v-Src-transformed cell lines | Q24650319 | ||
| A new model for ductal carcinoma in situ suggests strategies for treatment | Q24802734 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors | Q28207289 | ||
| Docking interactions in protein kinase and phosphatase networks | Q28271644 | ||
| Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor | Q28302317 | ||
| Epidermal growth factor receptor mutations in lung cancer | Q29615474 | ||
| The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation | Q30160222 | ||
| Structure and regulation of Src family kinases | Q30160827 | ||
| SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading | Q30167497 | ||
| Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. | Q52572763 | ||
| Activation segment exchange: a common mechanism of kinase autophosphorylation? | Q57937233 | ||
| Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers | Q70200246 | ||
| Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice | Q71606712 | ||
| Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor | Q71703153 | ||
| Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases. | Q30177032 | ||
| Involvement of pp60c-src with two major signaling pathways in human breast cancer | Q30194582 | ||
| c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function | Q30303639 | ||
| Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers | Q30453944 | ||
| Mechanism of biological synergy between cellular Src and epidermal growth factor receptor | Q30454480 | ||
| Role of c-Src tyrosine kinase in EGF-induced mitogenesis. | Q30471125 | ||
| Stat3 activation is required for cellular transformation by v-src | Q33786469 | ||
| Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene | Q34012640 | ||
| ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini | Q34187916 | ||
| Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. | Q34250172 | ||
| Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase | Q34383658 | ||
| c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis | Q34414942 | ||
| ErbB receptors: new insights on mechanisms and biology | Q34579265 | ||
| Endocytosis and intracellular trafficking of ErbBs | Q34827744 | ||
| Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression | Q35566222 | ||
| Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity | Q35641650 | ||
| The road to Src. | Q35920886 | ||
| New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally | Q36219999 | ||
| ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases | Q36326248 | ||
| A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma | Q36423957 | ||
| Association of p60c-src with endosomal membranes in mammalian fibroblasts | Q36533201 | ||
| Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity | Q36644521 | ||
| Epidermal growth factor receptor mutations in lung cancers. | Q36817294 | ||
| Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. | Q36940317 | ||
| Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking | Q37074180 | ||
| Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. | Q40135901 | ||
| EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes | Q40156909 | ||
| Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide | Q40336968 | ||
| The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. | Q40371716 | ||
| Activation of the Src family of tyrosine kinases in mammary tumorigenesis. | Q40605904 | ||
| Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells | Q40613260 | ||
| MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition | Q40710204 | ||
| Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor | Q41075249 | ||
| A new 180 kDa. urine protein marker associated with bladder cancer | Q41188835 | ||
| Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. | Q41273163 | ||
| c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. | Q41281287 | ||
| Site-specific association of c-Src with epidermal growth factor receptor in A431 cells | Q41344115 | ||
| The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants | Q42095201 | ||
| Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis | Q42796653 | ||
| Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells | Q42805935 | ||
| erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5858-5871 | |
| P577 | publication date | 2009-08-24 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential | |
| P478 | volume | 29 |
| Q34430965 | A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells. |
| Q54650700 | Acute ligand-independent Src activation mimics low EGF-induced EGFR surface signalling and redistribution into recycling endosomes. |
| Q35077627 | Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations. |
| Q91528840 | An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis |
| Q35207885 | Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors. |
| Q39160945 | Dasatinib inhibits mammary tumour development in a genetically engineered mouse model |
| Q37289437 | Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics |
| Q30009457 | Distinct effects of the mesenchymal dysplasia gene variant of murine Patched-1 protein on canonical and non-canonical Hedgehog signaling pathways |
| Q37619141 | Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes |
| Q35895556 | EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function |
| Q36115415 | Epidermal growth factor-stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis |
| Q24303562 | ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers |
| Q37663938 | ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation |
| Q34025197 | Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth |
| Q24297527 | Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase |
| Q33637170 | Interferon tau regulates PGF2alpha release from the ovine endometrial epithelial cells via activation of novel JAK/EGFR/ERK/EGR-1 pathways. |
| Q27315979 | Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS-p110 crosstalk |
| Q39347740 | KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer |
| Q35207787 | Lung cancer and lung injury: the dual role of ceramide |
| Q34432733 | Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor. |
| Q35779175 | Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis |
| Q38083427 | Multidrug therapy for polycystic kidney disease: a review and perspective |
| Q34149922 | Oncogenes and tumor suppressor genes |
| Q35479665 | Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. |
| Q28478429 | Polarized endocytosis of the keratinocyte growth factor receptor in migrating cells: role of SRC-signaling and cortactin |
| Q34939322 | Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer. |
| Q90054124 | Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping |
| Q42413098 | Similar requirement for clathrin in EGF- and HGF- stimulated Akt phosphorylation. |
| Q28391160 | Spatiotemporal regulation of Src and its substrates at invadosomes |
| Q39605666 | Src kinase mediates productive endocytic sorting of reovirus during cell entry. |
| Q35207876 | Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells |
| Q35371875 | Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival |
| Q57038071 | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone |
| Q27025646 | Targeting Src family kinases in anti-cancer therapies: turning promise into triumph |
| Q34525673 | The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment |
| Q34323926 | Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer. |
Search more.